Home » Topics » BioWorld Science

BioWorld Science
RSS

AC Immune patents agents targeting misfolded human TAR DNA-binding protein 43

Aug. 5, 2019

ALDH1 antigen-pulsed dendritic cells created at the University of Michigan

Aug. 5, 2019

MolMed describes chimeric antigen receptors targeting CD44

Aug. 5, 2019

A spoonful of sugar helps immunity calm down

Aug. 5, 2019

Better blood diagnostics with a different Holmes

Aug. 5, 2019

Oncoceutics reports phase I data for ONC-201

Aug. 5, 2019

Novel VEGFR-2 inhibitors show significant antiproliferative activity in preclinical models

Aug. 5, 2019

Vacuolar protein sorting 35 is a regulator of tau phosphorylation and neuropathology

Aug. 5, 2019

UBL4A acts as an authophagy inhibitor and tumor suppressor in pancreatic ductal adenocarcinoma

Aug. 5, 2019

VHIO and BST co-launch clinical trial of ViroTCell

Aug. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...